Patents by Inventor Janet E. Davis

Janet E. Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
    Publication number: 20240108572
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 4, 2024
    Inventors: Willard W. HENNEMANN, Bryan L. STEELMAN, Thomas J. WEBSTER, Janet E. DAVIS
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857672
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857673
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Grant
    Filed: October 24, 2022
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • Implantable cellular and biotherapeutic agent delivery canister
    Patent number: 11857670
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: January 2, 2024
    Assignee: NanoVault Medical, LLC
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
    Publication number: 20230059851
    Abstract: A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.
    Type: Application
    Filed: October 24, 2022
    Publication date: February 23, 2023
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. Webster, Janet E. Davis
  • IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
    Publication number: 20220142916
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Inventors: Willard W. Hennemann, Bryan L. Steelman, Thomas J. webster, Janet E. Davis
  • IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
    Publication number: 20200360270
    Abstract: The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.
    Type: Application
    Filed: August 5, 2020
    Publication date: November 19, 2020
    Inventors: Willard W. HENNEMANN, Bryan L. STEELMAN, Thomas J. WEBSTER, Janet E. Davis
  • Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
    Patent number: 9175261
    Abstract: Cell-based compositions and methods of their use to inhibit an adverse immune response such as graft versus host disease or rejection of transplanted tissue in a transplant recipient that is histocompatibility mismatched to the transplant donor are disclosed. The compositions and methods utilize postpartum-derived cells, such as cells derived from the placenta or umbilicus.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: November 3, 2015
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Alexander M. Harmon, Janet E. Davis
  • METHODS TO PROMOTE CELL DIFFERENTIATION
    Publication number: 20080063628
    Abstract: A method for promoting the differentiation of cells by contacting cells with a chromatin-remodeling agent to increase the expression of a transcriptional regulator.
    Type: Application
    Filed: September 11, 2006
    Publication date: March 13, 2008
    Inventors: Janet E. Davis, Ramie Fung